Review of Peripheral Neuropathy Measurement Tools for Cancer Patients
Author Information
Author(s): Silvia Belloni, Arianna Magon, Chiara Giacon, Francesca Savioni, Gianluca Conte, Rosario Caruso, Cristina Arrigoni
Primary Institution: University of Pavia
Hypothesis
This systematic review aimed to identify all validated self-report peripheral neuropathy scales and critically appraise their measurement properties.
Conclusion
The review found that while several instruments exist for assessing chemotherapy-induced peripheral neuropathy, none fully meet the necessary validation standards, highlighting a need for improved tools.
Supporting Evidence
- 46 eligible studies were identified and analyzed.
- Evidence quality for the instruments ranged from very low to moderate.
- All PROMs focused on chemotherapy-induced peripheral neuropathy, indicating a gap in addressing other causes.
Takeaway
This study looked at different questionnaires that help cancer patients report nerve problems caused by treatment, but none of them are perfect yet.
Methodology
The review followed the COSMIN methodology for systematic reviews of Patient-Reported Outcome Measures and the PRISMA statement, analyzing 46 studies and 16 PROMs.
Potential Biases
Most studies had deficiencies in content and structural validity, with few following recommended criteria for item development.
Limitations
The review did not provide a single qualitative scale description, limiting comprehensive understanding of each PROM.
Participant Demographics
The studies included adult cancer patients undergoing various treatments.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website